PATENT CLAIM ANALYSIS

Application Number: 16005488
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "230500"]

Abstract:
The present invention provides compounds represented by formula (I), pharmaceutically acceptable salts thereof, N-oxides thereof, solvates thereof or prodrugs thereof (wherein the characters are as defined in the description). The compounds represented by formula (I) have affinity and selectivity for the gamma-aminobutyric acid A receptor subunit alpha 5 (GABA A  α5) and act as GABA A  α5 negative allosteric modulators (GABA A  α5 NAM), so that they are useful in the prevention and/or treatment of diseases which are related to the GABA A  α5 such as Alzheimer's disease.

Claim (Index 19):
The pharmaceutical composition according to  claim 18 , wherein the disease which is related to the GABA A  \u03b15 is Alzheimer's disease, schizophrenia, Down syndrome or CNS conditions occurring after stroke.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 94.0
- Lexical Diversity: 1.64062
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15112647', '14208067', '14376307', '10149852', '11942480']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8176201664147037
- 35 USC 102 Novelty (BERT): 0.576757911036895
- Combined Prediction Score: 0.7935339408769229
- Mean Citation Score: 380.78577
- Max Citation Score: 515.1568
- Similarity Product: 374.69260286045073

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test